The collaborative efforts of the First Affiliated Hospital of Zhengzhou University and Grit Biotechnology exemplify the critical role of translational research in advancing cancer care. T cell ...

AI models analyzing tumor-infiltrating lymphocytes show promise in predicting outcomes for triple-negative breast cancer, but ...

Researchers at Karolinska Institutet have investigated how well different AI models can predict the prognosis of ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal ...

Department of Bio and Brain Engineering and KAIST Institute for Health Science and Technology, Korea Advanced Institute of Science and Technology (KAIST), Yuseong-gu, Daejeon34141, Republic of Korea ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

Researchers explore how AI-driven tumor-infiltrating lymphocyte (TIL) assessments outperform manual methods in precision but stress the need for robust datasets to ensure reliability in clinical ...

The biotech industry has been described as the Wild West of the stock market. While that level of success is only obvious in ...